BAKER BIOTECH CAPITAL II GP LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BIOTECH CAPITAL II GP LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BIOTECH CAPITAL II GP LLC. BAKER BIOTECH CAPITAL II GP LLC is 10% Owner in NEUROGEN CORP ($NRGN) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).

Latest Insider Trading Transactions of BAKER BIOTECH CAPITAL II GP LLC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, IBPI, NRGN, SGEN, GEVA, VPHM

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 22 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	109.15	395,000	43,114,250	1,201,000
Apr 22 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	109.15	268,000	29,252,200	806,000
Apr 22 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	93,000	232,500	4,967,000
Apr 18 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	63,000	157,500	4,874,000
Apr 14 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	109.15	538,000	58,722,700	538,000
Apr 12 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	139,000	347,500	4,811,000
Apr 08 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	31,000	77,500	4,213,000
Apr 08 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	139,000	347,500	4,672,000
Apr 08 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	320,000	800,000	4,533,000
Apr 01 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	4.96	10,816	53,674	264,773	254 K to 264.8 K (+4.26 %)
Apr 14 2005	IBPI	Ardea Biosciences, ...	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Buy	P	3.57	1,374	4,905	396,338	395 K to 396.3 K (+0.35 %)
Mar 02 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	303,000	757,500	4,182,000
Mar 02 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	137,000	342,500	3,879,000
Mar 02 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	344,000	860,000	3,742,000
Feb 14 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	10,000	25,000	91,000
Feb 14 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	29,000	72,500	81,000
Feb 14 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	P	2.50	14,000	35,000	52,000
Feb 14 2005	VPHM	VIROPHARMA INC	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Buy	P	3.02	193	583	193	0 to 193
Mar 30 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	4.90	5,934	29,072	253,957	248 K to 254 K (+2.39 %)
Mar 30 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	4.81	2,486	11,967	248,023	245.5 K to 248 K (+1.01 %)
Mar 30 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	4.90	809	3,964	245,537	244.7 K to 245.5 K (+0.33 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	4.96	71,227	353,250	244,728	173.5 K to 244.7 K (+41.05 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	4.99	51	254	173,501	173.5 K to 173.5 K (+0.03 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.04	74,167	373,557	173,450	99.3 K to 173.5 K (+74.70 %)
Mar 24 2005	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	4.88	5,234	25,537	99,283	94 K to 99.3 K (+5.57 %)
Nov 02 2004	GEVA	SYNAGEVA BIOPHARMA ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Sell	J	0.00	586,556	0	1,144,755	1.7 M to 1.1 M (-33.88 %)
Nov 03 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Option Exercise	J	2.50	34,385	85,963	249,730
Nov 03 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Option Exercise	J	6.25	42,981	268,631	312,162
Nov 03 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Sell	J	0.00	13,542	0	94,049	107.6 K to 94 K (-12.59 %)
Nov 02 2004	NRGN	NEUROGEN CORP	BAKER BIOTECH CAPITAL II GP LL ...	Director	Sell	J	0.00	268,465	0	2,039,196	2.3 M to 2 M (-11.63 %)
Nov 03 2004	IBPI	Ardea Biosciences, ...	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	J	1.90	7	13	56
Nov 03 2004	IBPI	Ardea Biosciences, ...	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	J	10.85	4,050	43,943	30,360
Nov 03 2004	IBPI	Ardea Biosciences, ...	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Option Exercise	J	2.07	18,414	38,043	147,311
Nov 03 2004	IBPI	Ardea Biosciences, ...	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Sell	J	0.00	48,266	0	389,034	437.3 K to 389 K (-11.04 %)
Sep 14 2004	GEVA	SYNAGEVA BIOPHARMA ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	13.32	22,322	297,329	1,731,311	1.7 M to 1.7 M (+1.31 %)
Sep 14 2004	GEVA	SYNAGEVA BIOPHARMA ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	13.56	17,859	242,152	1,708,989	1.7 M to 1.7 M (+1.06 %)
Sep 14 2004	GEVA	SYNAGEVA BIOPHARMA ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	12.99	1,450	18,837	1,691,130	1.7 M to 1.7 M (+0.09 %)
Sep 14 2004	GEVA	SYNAGEVA BIOPHARMA ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	12.55	33,484	420,348	1,689,680	1.7 M to 1.7 M (+2.02 %)
Aug 12 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.58	28,031	156,365	108,427	80.4 K to 108.4 K (+34.87 %)
Aug 12 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.42	4,481	24,283	80,396	75.9 K to 80.4 K (+5.90 %)
Aug 12 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.49	935	5,133	75,915	75 K to 75.9 K (+1.25 %)
Aug 12 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.32	12,298	65,400	74,980	62.7 K to 75 K (+19.62 %)
Aug 09 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.50	4,409	24,250	62,682	58.3 K to 62.7 K (+7.57 %)
Aug 09 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.54	17,480	96,860	58,273	40.8 K to 58.3 K (+42.85 %)
Aug 04 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.58	16,557	92,368	40,793	24.2 K to 40.8 K (+68.32 %)
Aug 04 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.71	13,665	78,057	24,236	10.6 K to 24.2 K (+129.27 %)
Aug 04 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.98	9,402	56,220	10,571	1.2 K to 10.6 K (+804.28 %)
Aug 04 2004	SGEN	SEATTLE GENETICS I ...	BAKER BIOTECH CAPITAL II GP LL ...	Director	Buy	P	5.89	1,169	6,885	1,169	0 to 1.2 K
Apr 21 2004	NRGN	NEUROGEN CORP	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Buy	P	7.00	2,241,286	15,689,002	2,307,661	66.4 K to 2.3 M (+3,376.70 %)
May 07 2004	IBPI	Ardea Biosciences, ...	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Buy	P	13.00	221,996	2,885,948	430,901	208.9 K to 430.9 K (+106.27 %)
Mar 17 2004	IBPI	Ardea Biosciences, ...	BAKER BIOTECH CAPITAL II GP LL ...	10% Owner	Buy	P	16.11	8,877	143,040	208,142	199.3 K to 208.1 K (+4.45 %)

Page: 1